Oxford-AstraZeneca trial finds vaccine not suitable for SA
A South African study of the Oxford-AstraZeneca vaccine trial has indicated that the vaccine does not have the required 60% efficacy against the variant of the coronavirus found in South Africa. The study was published in the New England Journal of Medicine. This is the first study to raise the alarm that, despite early successes with COVID-19 vaccines, further research is warranted on the next generation of COVID-19 vaccines. The […]
